Share
- Release Date: 08/11/12 17:10
- Summary: NTA: MLN: MLN NAV $0.8177 as at 6/11/12
- Price Sensitive: No
- Download Document 1.77KB
MLN
08/11/2012 15:10
NTA
REL: 1510 HRS Marlin Global Limited
NTA: MLN: MLN NAV $0.8177 as at 6/11/12
MLN NAV $0.8177 as at 6/11/12
Date 6/11/2012 31/10/2012
MLN NAV $0.8177 $0.8144
Share price close $0.70 $0.71
Discount 14% 13%
The above NAV is unaudited.
The net asset value per share is after deducting treasury stock (shares
acquired under the Marlin Global buyback programme).
The five largest portfolio holdings at 6 November 2012 are approximately as
follows:
Biotest (Germany) 6%
Sarin Technologies (Israel) 4%
Orthofix (United States) 4%
Stratec Biomedical (Germany) 4%
Wirecard (Germany) 4%
One of Marlin Global's investments, Fook Woo Group Limited ("Fook Woo"), has
voluntarily suspended its trading on the Hong Kong stock exchange since 28
November 2011. The value of Marlin Global's holding in Fook Woo has been
written down by 80%. Fook Woo comprises 1% of the portfolio as at the date of
this NAV announcement.
BACKGROUND
Marlin Global Limited ("Marlin") is a listed investment company that invests
in companies based outside of New Zealand and Australia. The investment
portfolio of Marlin is managed by Fisher Funds Management Limited, a
specialist fund manager with a track record of successful investing. Marlin
aims to offer investors competitive returns and access to a diversified
portfolio of investments through a single, investment vehicle. Marlin may
invest in listed international growth companies on any approved stock
exchange (excluding New Zealand or Australia) or unlisted international
companies not incorporated in New Zealand or Australia. The company listed on
the New Zealand Stock Exchange on 1 November 2007.
For further information please contact Marlin Global Limited, ph (09) 484
0365.
End CA:00229497 For:MLN Type:NTA Time:2012-11-08 15:10:53
